Internal Medicine, Rheumatology · Freehold, NJ
NPI
1225118086
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
900 W Main St Ste 5
Freehold, NJ, 07728
Phone (732) 431-4335
Groups this clinician bills Medicare through
Medicare paid, 2024
$319K
47,443 services
Medicare patients, 2024
395
Average age 75
Drug cost, 2024
$2.5M
2,432 prescriptions
Company payments, 2025
$2,199
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sawsan S Najmey was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 36,200 times for 14 patients. In total Sawsan S Najmey billed 47,443 services in 27 codes, and Medicare paid $319K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-28.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 36,200 | 14 | $3.62 | $131K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 6,600 | 60 | $0.10 | $664 |
| J0897 Injection, denosumab, 1 mg | Office | 1,800 | 20 | $20.73 | $37K |
| 99214 Office E&M - Established | Office | 907 | 340 | $100.37 | $91K |
| 96401 Chemotherapy Administration | Office | 257 | 34 | $60.07 | $15K |
| 99213 Office E&M - Established | Office | 168 | 110 | $67.95 | $11K |
| 20610 Joint Injection | Office | 101 | 54 | $56.61 | $5,718 |
| 99204 Office E&M - New | Office | 47 | 47 | $136.75 | $6,427 |
| 99215 Office E&M - Established | Office | 27 | 27 | $125.89 | $3,399 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 21 | 16 | $7.32 | $154 |
| 99203 Office E&M - New | Office | 12 | 12 | $80.82 | $970 |
By year: 2022 $460K for 54,556 services; 2023 $330K for 41,512 services; 2024 $319K for 47,443 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sawsan S Najmey prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 404 prescriptions and refills. In total Sawsan S Najmey wrote 2,432 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 404 | 986 | 115 | $13K |
| Hydroxychloroquine Sulfate Generic | 309 | 836 | 88 | $13K |
| Prednisone Generic | 224 | 422 | 81 | $2,210 |
| Alendronate Sodium Generic | 208 | 504 | 72 | $2,421 |
| Allopurinol Generic | 130 | 374 | 37 | $1,481 |
| Gabapentin Generic | 90 | 228 | 28 | $2,283 |
| Celecoxib Generic | 68 | 142 | 24 | $1,339 |
| Humira(Cf) Pen Adalimumab | 53 | 57 | Under 11 | $437K |
| Pregabalin Generic | 51 | 85 | 11 | $1,231 |
| Tramadol Hcl Generic | 47 | 47 | Under 11 | $163 |
| Enbrel Sureclick Etanercept | 46 | 60 | Under 11 | $542K |
| Duloxetine Hcl Generic | 45 | 89 | Under 11 | $1,029 |
| Meloxicam Generic | 44 | 126 | 16 | $205 |
| Orencia Clickject Abatacept | 38 | 38 | Under 11 | $229K |
| Colchicine Generic | 37 | 85 | 15 | $1,515 |
Brand drugs: - claims; generic drugs: 1,973 claims; opioid claims: 61.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sawsan S Najmey $2,199 ($2,199 in general payments such as food, travel and fees) from 15 companies. The largest payer was Janssen Biotech, Inc. with $811.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 36 | $811 |
| Abbvie Inc. ABBV | 23 | $395 |
| Amgen Inc. AMGN | 17 | $305 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $271 |
| UCB, Inc. UCB.BR | 5 | $157 |
| Pfizer Inc. PFE | 4 | $66.94 |
| GlaxoSmithKline, LLC. GSK | 4 | $60.3 |
| Genentech USA, Inc. ROG.SW | 2 | $29.14 |
| DePuy Synthes Sales Inc. JNJ | 1 | $17.14 |
| Almatica Pharma LLC | 1 | $15.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.